These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for co-existence of α-thalassemia in β-thalassemia and in HbE heterozygotes via an enzyme-linked immunosorbent assay for Hb Bart's and embryonic ζ-globin chain. Tatu T, Kiewkarnkha T, Khuntarak S, Khamrin S, Suwannasin S, Kasinrerk W. Int J Hematol; 2012 Apr; 95(4):386-93. PubMed ID: 22438184 [Abstract] [Full Text] [Related]
3. Routine screening for α-thalassaemia using an immunochromatographic strip assay for haemoglobin Bart's. Prayalaw P, Fucharoen G, Fucharoen S. J Med Screen; 2014 Sep; 21(3):120-5. PubMed ID: 24907301 [Abstract] [Full Text] [Related]
5. Detection of zeta-globin chains in the cord blood by ELISA (enzyme-linked immunosorbent assay): rapid screening for alpha-thalassemia 1 (Southeast Asian type). Ausavarungnirun R, Winichagoon P, Fucharoen S, Epstein N, Simkins R. Am J Hematol; 1998 Apr; 57(4):283-6. PubMed ID: 9544971 [Abstract] [Full Text] [Related]
7. Screening of (-SEA) α-thalassaemia using an immunochromatographic strip assay for the ζ-globin chain in a population with a high prevalence and heterogeneity of haemoglobinopathies. Jomoui W, Fucharoen G, Sanchaisuriya K, Fucharoen S. J Clin Pathol; 2017 Jan; 70(1):63-68. PubMed ID: 27312111 [Abstract] [Full Text] [Related]
9. Neonatal screening for alpha-thalassemia in southern Taiwan. Lin TM, Eng HL, Kuo PL, Wu HL. J Formos Med Assoc; 1992 Dec; 91(12):1213-5. PubMed ID: 1363647 [Abstract] [Full Text] [Related]
13. Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus. Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou PA, Kleanthous M. Hemoglobin; 2000 Aug; 24(3):171-80. PubMed ID: 10975437 [Abstract] [Full Text] [Related]
14. Development of a fluorescence immunochromatographic assay for the detection of zeta globin in the blood of (--(SEA)) α-thalassemia carriers. Wen L, Zhu P, Liu Y, Pan Q, Qu Y, Xu X, Li X, Fu N. Blood Cells Mol Dis; 2000 Aug; 49(3-4):128-32. PubMed ID: 22677106 [Abstract] [Full Text] [Related]
15. Prenatal diagnosis of Hb Bart's hydrops fetalis caused by a genetic compound heterozygosity for two different alpha-thalassemia determinants. Siriratmanawong N, Pinmuang-Ngam C, Fucharoen G, Fucharoen S. Fetal Diagn Ther; 2007 Aug; 22(4):264-8. PubMed ID: 17369692 [Abstract] [Full Text] [Related]
16. A multicenter trial of the effectiveness of zeta-globin enzyme-linked immunosorbent assay and hemoglobin H inclusion body screening for the detection of alpha0-thalassemia trait. Lafferty JD, Barth DS, Sheridan BL, McFarlane AG, Halchuk LM, Raby A, Crowther MA. Am J Clin Pathol; 2008 Feb; 129(2):309-15. PubMed ID: 18208812 [Abstract] [Full Text] [Related]
19. Hemoglobin Lepore EF Bart's disease: a molecular, hematological, and diagnostic aspects. Chaibunruang A, Fucharoen G, Jetsrisuparb A, Fucharoen S. Ann Hematol; 2011 Nov; 90(11):1337-40. PubMed ID: 21302111 [Abstract] [Full Text] [Related]
20. Accurate prenatal diagnosis of Hb Bart's hydrops fetalis in daily practice with a double-check PCR system. Karnpean R, Fucharoen G, Fucharoen S, Sae-ung N, Sanchaisuriya K, Ratanasiri T. Acta Haematol; 2009 Nov; 121(4):227-33. PubMed ID: 19546525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]